Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial

Early norepinephrine was significantly associated with increased shock control by 6 hours. Further studies are needed before this approach is introduced in clinical resuscitation practice. Clinical trial registered with www.clinicaltrials.gov (NCT01945983) (CENSER trial).